GUAIFENESIN and COUGH

Overview

COUGH is the #7 most commonly reported adverse reaction for GUAIFENESIN, manufactured by RB Health (US) LLC. There are 1,557 FDA adverse event reports linking GUAIFENESIN to COUGH. This represents approximately 2.5% of all 61,553 adverse event reports for this drug.

Patients taking GUAIFENESIN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for GUAIFENESIN, but still significant enough to appear in the safety profile.

Other Side Effects of GUAIFENESIN

In addition to cough, the following adverse reactions have been reported for GUAIFENESIN:

• DRUG INEFFECTIVE — 2,450 reports
• DYSPNOEA — 2,179 reports
• FATIGUE — 1,782 reports
• NAUSEA — 1,742 reports
• DIARRHOEA — 1,645 reports
• PNEUMONIA — 1,643 reports
• HEADACHE — 1,506 reports
• DIZZINESS — 1,400 reports
• PAIN — 1,252 reports
• OFF LABEL USE — 980 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does GUAIFENESIN cause COUGH?

COUGH has been reported as an adverse event in 1,557 FDA reports for GUAIFENESIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with GUAIFENESIN?

COUGH accounts for approximately 2.5% of all adverse event reports for GUAIFENESIN, making it a notable side effect.

What should I do if I experience COUGH while taking GUAIFENESIN?

If you experience cough while taking GUAIFENESIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages